UCHL5 and bladder transitional cell carcinoma: In the TCGA-BLCA cohort, patients classified in the UCHL5 high-expression group occupied higher grades (p < 0.001) than those classified in the low-expression group, the latter of which is conducive to increased survival (p = 0.009).